Nostopharma

Bethesda, United States

Nostopharma provides treatment for orthopedic patients.

$250K raised

Jan 2025

Venture - Series Unknown

Top Investors

National Science FoundationTEDCO

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Nostopharma raised?

Nostopharma has raised $250K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.

Who are Nostopharma's investors?

Nostopharma's investors include National Science Foundation, TEDCO.

Where is Nostopharma headquartered?

Nostopharma is headquartered in Bethesda, United States.

What does Nostopharma do?

Nostopharma provides treatment for orthopedic patients.

What stage is Nostopharma at?

Nostopharma is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 23, 2025.

MLA

"Nostopharma — Funding & Investors." VCBacked, January 23, 2025, https://www.vcbacked.co/company/nostopharma. Accessed June 4, 2026.

APA

VCBacked. (2025). Nostopharma — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/nostopharma

Wikipedia (cite web)

{{cite web |title=Nostopharma — Funding & Investors |url=https://www.vcbacked.co/company/nostopharma |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 23, 2025.